Award recordCONTRACT

PROGENICS PHARMACEUTICALS INC

PIID 36C24925N0010· VHA· 249-NETWORK CONTRACT OFFICE 9 (36C249)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $1,051,561 net obligations· UEI YLYKVRPCTCR3· MA

Description

PYLARIFY PET RADIOPHARMACEUTICAL MOD TO INCREASE QUANTITIES.

Base award description: PYLARIFY PET RADIOPHARMACEUTICAL

First action · last action
2024-10-22 · 2026-04-23
Transactions
3
First transaction's obligation
$902,180
Base + all options value (sum of deltas)
$1,051,561
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C24923A0010
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,129,529$0Base award · 2024-10-22 · this action $902,180 · running total $902,180Modification P00001 · 2025-10-30 · this action $227,349 · running total $1,129,529Modification P00002 · 2026-04-23 · this action -$77,969 · running total $1,051,561
  • Base2024-10-22+$902,180= $902,180
  • Mod P000012025-10-30+$227,349= $1,129,529
  • Mod P000022026-04-23-$77,969= $1,051,561
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-10-22+$902,180$902,180PYLARIFY PET RADIOPHARMACEUTICAL
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-10-30+$227,349$1,129,529PYLARIFY PET RADIOPHARMACEUTICAL MOD TO INCREASE QUANTITIES.
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2026-04-23−$77,969$1,051,561PYLARIFY PET RADIOPHARMACEUTICAL MOD TO INCREASE QUANTITIES.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI YLYKVRPCTCR3)

AwardOffice · PSC / listingNet obligationsFY
36C24626N0890246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$1,212,530FY2026
36C24626A0027246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26226F0313262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$180,436FY2026
36C25026N0655250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$721,744FY2026
36C26026F0298260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$469,134FY2026
36C25026N0531250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$559,352FY2026

Other recipients under 6505 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24926N0676AMICUS THERAPEUTICS US, LLC249-NETWORK CONTRACT OFFICE 9 (36C249)$68,519FY2026
36C24926N0651BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$378,650FY2026
36C24926N0658BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0590BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0589BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24925N0010_3600_36C24923A0010_3600 · retrieved 2026-09-26.